CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease.

[1]  Kyoko Nakamura,et al.  Flow cytometric assessment of CD15+CD117+ cells for the detection of minimal residual disease in adult acute myeloid leukaemia , 2000, British journal of haematology.

[2]  A. Órfão,et al.  Detection of minimal residual disease in acute leukemia. , 1995, Blood.

[3]  D. Campana,et al.  Detection of minimal residual disease in acute leukemia by flow cytometry. , 1999, Cytometry.

[4]  A. Órfão,et al.  An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia. , 1999, Cytometry.

[5]  A. Órfão,et al.  Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL , 1999, Leukemia.

[6]  Roberti,et al.  Expression and functional role of urokinase‐type plasminogen activator receptor in normal and acute leukaemic cells , 1998, British journal of haematology.

[7]  A. Órfão,et al.  The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). , 1998, Blood.

[8]  M. Loken,et al.  Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. , 1998, American journal of clinical pathology.

[9]  D. Catovsky,et al.  Detection of minimal residual disease in B‐lineage acute lymphoblastic leukaemia by quantitative flow cytometry , 1998, British journal of haematology.

[10]  Elaine Coustan-Smith,et al.  Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia , 1998, The Lancet.

[11]  A. Órfão,et al.  Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. , 1998, Haematologica.

[12]  S. Tura,et al.  High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate , 1997, Leukemia.

[13]  Marcos González,et al.  Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients , 1997 .

[14]  L. Ginaldi,et al.  Differential expression of CD3 and CD7 in T‐cell malignancies: a quantitative study by flow cytometry , 1996, British journal of haematology.

[15]  G. Janossy,et al.  Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). , 1996, Blood.

[16]  F. Lanza,et al.  Quantitation of hemopoietic cell antigens in flow cytometry. , 1996, European journal of histochemistry : EJH.

[17]  D. Catovsky,et al.  Quantitative flow cytometry can distinguish between normal and leukaemic B‐cell precursors , 1995, British journal of haematology.

[18]  A Orfao,et al.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.

[19]  A. Órfão,et al.  Immunophenotype of c‐kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML , 1995, British journal of haematology.

[20]  J. V. van Dongen,et al.  Immunophenotypic and immunogenotypic detection of minimal residual disease in acute lymphoblastic leukemia. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[21]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.